Additionally, EDOA and EDOR were tested against enzymes such as acetylcholinesterase, butyrylcholinesterase, and α-glycosidase, which are associated with common diseases such as diabetes, Alzheimer’s disease, and glaucoma. This evidence concerns the gene BCHE and early-onset autosomal dominant Alzheimer disease.